Vulnerability Details : CVE-2023-33365
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
Vulnerability category: Directory traversal
Products affected by CVE-2023-33365
- cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2023-33365
0.16%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 53 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2023-33365
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
7.5
|
HIGH | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N |
3.9
|
3.6
|
NIST |
CWE ids for CVE-2023-33365
-
The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.Assigned by: nvd@nist.gov (Primary)
References for CVE-2023-33365
-
https://claroty.com/team82/disclosure-dashboard/cve-2023-33365
CVE-2023-33365 | ClarotyThird Party Advisory
-
https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291
Version 2.9.1 (V2.9.1.25) []Release Notes;Vendor Advisory
Jump to